ECS Botanics Holdings Ltd (ASX: ECS) Share Price and News

Mr King has over 20 years' experience in domestic and international legal, financial, and corporate matters. Mr. King is a director of a boutique corporate advisory and compliance business where he specialises in corporate and strategic advice and managing legal issues associated with clients. He spent several years in London where he worked with Allen and Overy LLP and Debevoise & Plimpton LLP and has experience, particularly in relation to cross border private equity, leveraged buy-out acquisitions and acting for banks, financial institutions, and corporate issuers in respect of debt and equity capital raisings. He regularly advises ASX listed companies on corporate and commercial matters.

Mr Nitsche is the founder and Executive Director of ARQ Capital, a boutique corporate advisory firm based in Perth, Western Australia. He has experience in equity capital markets, advising on deal structuring for IPO's, equity capital raisings, mergers, and acquisitions. From 2011 to 2014 Michael served as Institutional Advisor and Associate Director at two of Australia's stockbroking firms. Michael has held directorships that span public and private boards across multiple market sectors.

Ms Schoerie has held Australian business leader positions of organisations such as GE, ThermoFisher and Ventia, having shown an ability to deliver bottom- and top-line growth across different geographies and industries. Nan's passion for delivering customer value and her determination to deliver outcomes resulted in customer retention rates whilst regularly securing annuity contracts, some valued at over $200m. As Managing Director Nan is responsible for managing the overall business, ensuring the safety and wellbeing of employees, building a performing Company culture, ensuring Customer satisfaction, and delivering on the Company's financial objectives. In addition, Nan works with the board to provide strategic guidance, and ensure good governance.

Dr Swift With nearly 20 years experience across the healthcare sector, Dr Swift joins the ECS Board with a track record in driving transformative health initiatives and leading strategic change in complex environments. Dr Swift has held senior positions in companies at the forefront of health system management, public health, infectious diseases, digital health, and medical research, including a decade at The Boston Consulting Group where she focused on business strategy, healthcare innovation, and enhancing patient outcomes. Dr Swift serves on several boards, including the Innovation & Enterprise Advisory Board at the University of Melbourne School of Medicine, Dentistry, and Health Sciences. She also chairs the Finance Committee at GPEx, where she holds the position of Vice-Chair. In addition to her executive and board roles, Dr Swift has held academic appointments at the Universities of Oxford and Adelaide.

-

-

-